Skip to main content

Advertisement

SpringerLink
Log in

Localized renal cell carcinoma

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

The last decade has brought dramatic changes in our understanding of localized renal tumors. Due to vast improvements in the abdominal imaging modalities of computed tomography (CT), ultrasound, and magnetic resonance imaging (MRI), approximately two-thirds of patients at our center have their renal tumors discovered incidentally. This tumor stage and size migration has vastly improved survival rates; more than 75% of patients with localized renal tumors achieve cure after surgical resection. In addition, the increased presentation of small, incidental tumors has increased the therapeutic options for urologic surgeons with surgical or tumor ablative techniques who now consider preservation of renal function as a goal equally important to local tumor control. Renal cortical tumors, viewed previously as a single type of cancer (ie, hypernephroma, renal cell carcinoma) with a uniform metastatic potential, are far more complex in nature. Renal cortical tumors are a family of neoplasms with distinct histological subtypes and distinct cytogenetic and molecular defects. Metastatic potential, once thought to be dependent only on tumor size, grade, and stage, varies according to tumor histologic subtype, ranging from the most potentially malignant conventional clear cell carcinoma, to the indolent papillary and chromophobe carcinomas, to the virtually benign renal oncocytoma. Surgical approaches to the localized renal cortical tumors now include the classic radical nephrectomy, kidney-sparing surgery, and innovative techniques that involve laparoscopy. New therapeutic modalities, such as renal cryosurgery and radiofrequency ablation, are under active investigation. Whether these new approaches to localized renal tumors will supplement or replace current surgical techniques will depend on the findings of carefully designed and controlled clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Porena M, Vespasiani G, Rosi P, et al.: Incidentally detected renal cell carcinoma. J Clin Ultrasound 1992, 20:395–400.

    Article  PubMed  CAS  Google Scholar 

  2. Rabbani F, Grimaldi G, Russo P: Multiple primary malignancies in renal cell carcinoma. J Urol 1998, 160:1255–1259.

    Article  PubMed  CAS  Google Scholar 

  3. Silver DA, Morash C, Brenner P, et al.: Pathological findings at the time of nephrectomy for renal mass. Ann Surg Oncol 1997, 4:570–574.

    Article  PubMed  CAS  Google Scholar 

  4. Kovacs G, Akhtar M, Beckwith B, et al.: The Heidelberg classification of renal cell tumors. J Pathol 1997, 183:131.

    Article  PubMed  CAS  Google Scholar 

  5. Illiopolulos O, Eng C: Genetic and clinical aspects of familial renal neoplasms. Semin Oncol 2000, 27:138–149.

    Google Scholar 

  6. Zambrano NR, Lubensky IA, Merino MJ, et al.: Histopathology and molecular genetics of renal tumors: toward unification of a classification system. J Urol 1999, 162:1246–1258. A review article that describes the great advances in understanding of the molecular defects in renal cortical tumors.

    Article  PubMed  CAS  Google Scholar 

  7. Walther MM, Choyke PL, Glenn G, et al.: Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 1999, 161:1475. A study that evaluates a 3 cm. threshold for performing renal parenchymal sparing surgery in patients with von Hippel-Lindau disease and hereditary papillary renal cancer. In VHL concerns for recurrent renal tumors are balanced against equivalent concerns for preservation of renal function.

    Article  PubMed  CAS  Google Scholar 

  8. Zbar B, Glenn G, Lubensky I, et al.: Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol 1995, 153:907–912. A study that describes another hereditary form of renal cancer.

    Article  PubMed  CAS  Google Scholar 

  9. Weirich G, Glenn G, Junker K, et al.: Familial renal oncocytoma: clinicopathological study of 5 families. J Urol 1998, 160:335.

    Article  PubMed  CAS  Google Scholar 

  10. Torro JR, Glenn G, Duray P, et al.: Birt Hogg-Dube syndrome: a novel marker of kidney neoplasia. Arch Derm atol 1999, 135:1195.

    Article  Google Scholar 

  11. Kattan MW, Reuter VE, Motzer RJ, et al.: A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001, 166:63–67. An informatics study that provides prognostic information based on tumor size, histology, P stage, and symptoms.

    Article  PubMed  CAS  Google Scholar 

  12. Grimaldi G, Reuter V, Russo P: Bilateral non-familial renal cell carcinoma. Ann Surg Oncol 1998, 5:548–552.

    Article  PubMed  CAS  Google Scholar 

  13. LauKO, Blute ML, Weaver AL, et al.: Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with a normal contralateral kidney. Mayo Clin. Proc 2000, 75:1236–1242. An important study that describes the deleterious effect on renal function of radical nephrectomy compared with partial nephrectomy in matched patients.

    Article  PubMed  CAS  Google Scholar 

  14. McKiernan JM, Simmons R, Katz J, et al.: The natural history of renal insufficiency following partial or radical nephrectomy for renal tumors less than 4 cm. J Urol 2001, 165:160A.

    Google Scholar 

  15. Velosa JA, Anderson CF, Torres VE, et al.: Long-term renal status of kidney donors: calculated small risk of renal donation. Transplant Proc 1985, 17:100.

    Google Scholar 

  16. UzzoRG, Novick AC: Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001, 166:6–18. A comprehensive review of the results and the complications of kidney-sparing surgery.

    Article  PubMed  CAS  Google Scholar 

  17. Steinbach F, Stockle M, Muller SC, et al.: Conservative surgery of renal cell tumor in 140 patients: 21 years of experience. J Urol 1992, 148:24–29.

    PubMed  CAS  Google Scholar 

  18. Lerner SE, Hawkins CA, Blute ML, et al.: Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol 1996, 155:1868.

    Article  PubMed  CAS  Google Scholar 

  19. Lee CT, Katz J, Shi W, et al.: Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol 2000, 73:730–736. An outcomes analysis of patients treated by partial or radical nephrectomy for renal tumors less than 4 cm in size. There was no difference in rates of local and systemic recurrence or in rates of perioperative complications whether a patient was treated by radical or partial nephrectomy.

    Google Scholar 

  20. Russo P, Goetzl M, Simmons R, et al.: Preliminary experience with partial nephrectomy for renal tumors greater than 4 cm in diameter. Paper presented at the Society of Surgical Oncology. March 15, 2001. Washington, DC, USA.

  21. McLaughlin JK, Lipworth L: Epidemiological aspects of renal cell carcinoma. Semin Oncol 2000, 27:115–123.

    PubMed  CAS  Google Scholar 

  22. Robson CJ: Radical nephrectomy for renal cell carcinoma. J Urol 1963, 89:37.

    PubMed  CAS  Google Scholar 

  23. Russo P: Renal cell carcinoma: presentation, staging and surgical management. Semin Oncol 2000, 27:160–176.

    PubMed  CAS  Google Scholar 

  24. Campbell SC, Novick AC, Streem SB, et al.: Complications of nephron sparing surgery for renal tumors. J Urol 1994, 151:1177–1180. In a series of 259 patients treated by kidney-sparing surgery, perioperative mortality was 1.5%, urinary fistula 17.4%, prolonged ATN 7.3%, and permanent dialysis 5.4%.

    PubMed  CAS  Google Scholar 

  25. Novick AC, Gephardt G, Guiz B, et al.: Long term follow up after partial removal of solitary kidney. N Engl J Med 1991, 325:1058–1062.

    Article  PubMed  CAS  Google Scholar 

  26. Gilbert BR, Russo P, Zirinsky K, et al.: Intraoperative sonography: application in renal cell carcinoma. J Urol 1988, 139:582–584.

    PubMed  CAS  Google Scholar 

  27. Kerbl K, Clayman RV: Advances in laparoscopic renal and ureteral surgery. Eur Urol 1994, 25:1–6.

    PubMed  CAS  Google Scholar 

  28. Gill IS, Schweizer D, Hobart MG, et al.: Retroperitoneal laparoscopic radical nephrectomy: the Cleveland Clinic experience. J Urol 2000, 163:1665. An evaluation of the technical feasibility of retroperitoneoscopic radical nephrectomy and a comparison of its results with open surgery in a contemporary cohort.

    Article  PubMed  CAS  Google Scholar 

  29. Gill IS, Kavoussi LR, Clayman RV, et al.: Complications of laparoscopic nephrectomy in 185 patients: a multi-institutional review. J Urol 1995, 15:479–483.

    Google Scholar 

  30. Russo P: Evolving understanding and surgical management of renal cortical tumors. Mayo Clin Proc 2000, 75:1233–1235.

    PubMed  CAS  Google Scholar 

  31. Gill IS, Novick AC, Soble JJ, et al.: Laparoscopic renal cryoablation: initial clinical series. Urology 1998, 52:543–551.

    Article  PubMed  CAS  Google Scholar 

  32. Remer EM, Weinberg EJ, Oto A, et al.: MR imaging of the kidneys after laparoscopic cryoablation. AJR Am J Roentgenol 2000, 174:635–640.

    PubMed  CAS  Google Scholar 

  33. Sung GT, Meraney AM, Schweizer DK, et al.: Laparoscopic renal cryoablation in 50 patients: intermediate follow up. J Urol 2001, 165:158A.

    Google Scholar 

  34. Walther MC, Shawker TH, Libutti SK, et al.: A phase 2 study of radio frequency interstitial tissue ablation of localized renal tumors. J Urol 2000, 163:1424–1427.

    Article  PubMed  CAS  Google Scholar 

  35. Pavlovich CP, Wood BJ, Choyke PL, et al.: Percutaneous radiofrequency ablation (RFA) of small (3cm) renal neoplasms: initial clinical series. J Urol 2001, 165:157A.

    Google Scholar 

  36. Michaels MJ, Silverman M, Libertino JA: Absence of total tumor necrosis in radiofrequency ablated renal tumors. J Urol 2001, 21A.

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, 10021, New York, NY, USA

    Paul Russo MD, FACS

Authors
  1. Paul Russo MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russo, P. Localized renal cell carcinoma. Curr. Treat. Options in Oncol. 2, 447–455 (2001). https://doi.org/10.1007/s11864-001-0050-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-001-0050-4

Keywords

Search

Navigation